Back to search

Spain· ES:1151064001

IMLYGIC 1x10e6 UFP/ml solucion inyectable

A medicinal product containing talimogén laherparepvec, registered in Spain by Amgen Europe B.V..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedIMLYGIC 1x10e6 UFP/ml solucion inyect…ATC—REGISTER NO.ES:1151064001PACKS LISTED0CHECKEDJune 3, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
talimogén laherparepvec
Manufacturer
Amgen Europe B.V.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
June 3, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Talimogén laherparepvec in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All talimogén laherparepvec products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Imlygic
  • Norway · Imlygic

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/55b3e560-0919-402c-ac1c-1885df8fcf78
GET /v1/drugs/55b3e560-0919-402c-ac1c-1885df8fcf78?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Uso Hospitalario",
  "estado": "{\"aut\":1453423975000}",
  "nregistro": "1151064001",
  "substance": "talimogén laherparepvec"
}

See everything about talimogén laherparepvec.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.